Serevent
- Resources
A U.S. Food and Drug Administration (FDA) advisory panel says that asthma and COPD drugs Advair and Symbicort are safe for use, but Serevent and Foradil are too risky for children and adults with asthma. The problem, experts say, is that patients taking long-acting beta agonists (LABAs) Serevent and Foradil often do not take a steroid inhaler in conjunction with their LABA, which may increase the risk of death. The FDA will now consider the recommendations of the advisory panel and some experts...
Read moreMore information on "Serevent"
From Our Experts
Serevent and Foradil carry more risks, and benefits, than other...
In this entry, I would like to discuss some recent findings on two similar medications that have significantly changed the landscape of... Read more »
Serevent and Foradil: Why Aren’t They Worried About COPD’ers?
Last month the FDA (Food and Drug Administration) voted unanimously that the benefit of Advair and Symbicort outweighed the risks of... Read more »
Understanding Black Box Warnings for Asthma Medicines
Some of the most effective asthma medicines are inhaled steroids, and the downside to this is that the word "steroid" has a bad reputation.... Read more »
Old, New and Future Approaches to Asthma Treatment
New approaches to asthma treatment Earlier last month, I attended an international conference on clinical and research advances in asthma... Read more »
Advair and Symbicort: “Benefits Outweigh Risk” says an FDA...
Last week, the Food and Drug Administration (FDA) listened to presentations and comments from several members of an expert FDA advisory... Read more »
From Our Sources
Serevent plus Flovent may reduce hospital visits
Combining the asthma treatment Serevent with the inhaled corticosteroid Flovent may reduce the risk of asthma hospitalization, researchers say. In a... Read more »
Clinical trial: Asthma and genetics in patients using Advair o...
This is a study sponsored by GlaxoSmithKline to determine the relationship between asthma and genetics in patients using Advair and Serevent. This... Read more »
Clinical trial: Advair vs. Serevent in patients of African des...
GlaxoSmithKline is conducting a clinical trial to see if fluticasone propionate plus salmeterol (Advair) is better than fluticase propionate alone... Read more »
New data review adds more evidence that Advair, Serevent may b...
Researchers at Santa Clara Medical Center have found that patients who take Advair and Serevent to control asthma have nearly triple the risk of... Read more »
FDA warned on risks associated with 4 asthma inhalers
The U.S. Food and Drug Administration (FDA) is again concerned about the safety of four popular asthma inhalers. Two federal safety officials wrote... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
